In order to safeguard the high standards the LBG sets for its institutes, the society has implemented a systematic quality assurance procedure. This includes ongoing expert consultation and supervision by a scientific advisory board, which meets annually with each research team to review progress and give advise on future avenues. They provide a written report, which serves as a basis for decisions on the research programme.
With five internationally acknowledged scientists in the field of cancer research and transgenesis the SAB of the LBI-CR boasts crucial expertise, which has proven instrumental for the implementation of a successful research programme in a highly competitive environment like cancer research. The team leaders are therefore indebted to the contributions of the SAB-members.
Prof. A. Thomas Look
Dept. of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School
Boston, U.S.A.
Prof. Radek Skoda
Department of Biomedicine, University Hospital Basel
Basel, Switzerland
Prof. Kay Uwe Wagner
University of Nebraska, Medical Center
Nebraska, USA